EORTC organizing session on Cancer and Employment at European Business Summit 2015 in Brussels
14 Apr 2015
European Business Summit, Europe’s key meeting place for business leaders and decision makers, is the debate platform where Business and Politics Shape the Future. Every year, the EBS attracts more than 2000 participants from over 60 countries, including: the President of the European Commission, members of the European Commission, members of the European Parliament, Heads of State, CEOs, high-ranking individuals and about 200 journalists and broadcasters. After the steam engine, mass production and automation, the fourth industrial revolution is on its way, fueled by the digitalisation. Under the theme ‘Europe 4.0 – Delivering a vision for the future of Europe’, EBS 2015 will focus on how the industry and the society are impacted by the digitalisation.
The EORTC is organizing a session at EBS 2015 on “Cancer Survivorship & Employment Session: How can businesses tackle new societal issues?” on 6 May 2015 at Palais d’Egmont, Brussels, from 14:30 to 16:30 in the presence of H.R.H Princess Astrid of Belgium.
This unique session will be Chaired by Françoise Meunier, Director Special Projects, EORTC, and M. Vermaerke , CEO FEBELFIN, and moderated by Andrew Jack of the Financial Times and Peter O’Donnell of the European Voice. The program includes a keynote lecture by Marianne Thyssen, EU Commissioner Employment, Social affairs, Skills and Labor Mobility, and presentations by Isabelle Lebrocquy, Cancer Survivor, Patient Advocate and Social Entrepreneur, Richard Ellis, Director of Corporate Social Responsibilities, Walgreens Boots Alliance, Ingrid Kössler, European Economic and Social Committee, and Ingrid Klingmann, Chairman, European Forum for Good Clinical Practice.
Indeed, the success cancer clinical research has achieved over the past 40 years has created unique challenges. Many cancer patients now become cancer survivors and are confronted with unanticipated societal problems related to quality of life or obtaining mortgages, appropriate insurance, or gainful employment. Consequently, the EORTC is also focusing attention on cancer survivorship and addressing challenges faced by patients cured of cancer.
The First EORTC Cancer Survivorship Summit held in January 2014 was a great success and sensitized participants from all walks of life on a variety of problems faced by cancer survivors after being cured from cancer. These include finding or keeping a job, obtaining a mortgage or insurance, etc.
Register for the European Business Summit. Registration requests are subject to approval by the European Business Summit Organizers.
Visit EBS 2015 for more information.
Program of the session in the presence of H.R.H Princess Astrid of Belgium
| 14:00-14:30 | CHAIRING THE SESSION: Françoise Meunier, Director Special Projects, EORTC (BE) and M. Vermaerke , CEO FEBELFIN (BE) |
| 14:30-16:30 | MODERATORS: Andrew Jack, Financial Times (GB) & Peter O’Donnell, European Voice (BE) WELCOME: Françoise Meunier, Director Special Projects, EORTC (BE) |
| KEYNOTE LECTURE Marianne Thyssen, EU Commissioner Employment, Social affairs, skills and labour mobility (BE) |
|
| PRESENTATIONS Isabelle Lebrocquy, Cancer Survivor, Patient Advocate and Social Entrepreneur (O Puce), NL Richard Ellis, Director of Corporate Social Responsibilities, Walgreens Boots Alliance, GB Ingrid Kössler, European Economic and Social Committee, SE Ingrid Klingmann, Chairman, European Forum for Good Clinical Practice (EFGCP), BE |
|
| DEBATE |
| 16:30 | End of the session |
Related News
CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer
24 Jun 2026
EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials
24 Jun 2026
New study confirms a key quality of life tool can be used with adolescents with cancer
9 Jun 2026
“Changing practice, improving lives”: EORTC publishes its Annual Report 2025
8 Jun 2026
This Clinical Trials Day, EORTC announces the upcoming Summit for Clinical Cancer Research
20 May 2026
Long-term EORTC trial challenges assumptions about lymph node radiation therapy in breast cancer
17 May 2026
Multinational study provides new evidence for the value of response-adapted, personalised treatment in Hodgkin lymphoma
1 May 2026
EORTC’s presence at ESTRO 2026
30 Apr 2026
Independent, academic cancer trials are vital to improve patient outcomes worldwide
28 Apr 2026
EORTC Imaging Group Becomes the Diagnostic and Therapeutic Imaging Group
24 Apr 2026
